SXR6 📈 iShares MSCI Japan SRI - Overview

Exchange: XETRA • Country: Germany • Currency: EUR • Type: Etf • ISIN: IE00B53QFR17 • Japan Large-Cap Equity

SXR6: Equity, Index, Funds, Investment, Management

‣ Company URL: http://www.blackrock.com ‣ Domicile: Ireland ‣ Index Name: Morningstar Japan TME NR JPY

Additional Sources for SXR6 ETF

Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle

SXR6 ETF Overview

Market Cap in USD 1,079m
Category Japan Large-Cap Equity
TER 0.20%
IPO / Inception 2017-03-02

SXR6 ETF Ratings

Growth 5y 37.5%
Fundamental -
Dividend -
Rel. Strength Industry -34.3
Analysts -
Fair Price Momentum 6.36 EUR
Fair Price DCF -

SXR6 Dividends

No Dividends Paid

SXR6 Growth Ratios

Growth Correlation 3m 23.1%
Growth Correlation 12m 74.8%
Growth Correlation 5y 56.8%
CAGR 5y 3.53%
CAGR/Mean DD 5y 0.39
Sharpe Ratio 12m 0.35
Alpha -4.55
Beta 0.44
Volatility 14.57%
Current Volume 25.1k
Average Volume 20d 116.2k
What is the price of SXR6 stocks?
As of December 22, 2024, the stock is trading at EUR 6.72 with a total of 25,103 shares traded.
Over the past week, the price has changed by -3.42%, over one month by +1.62%, over three months by +0.28% and over the past year by +12.26%.
Is iShares MSCI Japan SRI a good stock to buy?
Partly, yes. Based on ValueRay Analyses, iShares MSCI Japan SRI (XETRA:SXR6) is currently (December 2024) ok to buy, but has to be watched. It has a Growth Technical Rating of 37.47 and therefor an somewhat technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of SXR6 as of December 2024 is 6.36. This means that SXR6 is currently overvalued and has a potential downside of -5.36%.
Is SXR6 a buy, sell or hold?
iShares MSCI Japan SRI has no consensus analysts rating.
What are the forecast for SXR6 stock price target?
According to ValueRays Forecast Model, SXR6 iShares MSCI Japan SRI will be worth about 7 in December 2025. The stock is currently trading at 6.72. This means that the stock has a potential upside of +3.42%.
Issuer Forecast Upside
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 7 3.4%